APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Site-Directed Mutagenesis Services

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gene Site-Directed Mutagenesis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

11 April 2026196 pages

Choose your research edition.

Industry ResearchGene Site-Directed Mutagenesis Services Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Site-Directed Mutagenesis Services Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Gene Site-Directed Mutagenesis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Site-Directed Mutagenesis Services Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Gene Site-Directed Mutagenesis Services Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Gene Site-Directed Mutagenesis Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gene Site-Directed Mutagenesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Site-Directed Mutagenesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Site-Directed Mutagenesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gene Site-Directed Mutagenesis Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gene Site-Directed Mutagenesis Services include Azenta Life Sciences, GenScript, Thermo Fisher Scientific, Charles River Laboratories, Genewiz, Creative Biolabs, NovoPro Bioscience Inc., ACGT, Inc. and Epoch Life Science, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gene Site-Directed Mutagenesis Services market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Site-Directed Mutagenesis Services and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Site-Directed Mutagenesis Services revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Site-Directed Mutagenesis Services market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Site-Directed Mutagenesis Services Segment by Company

Azenta Life Sciences

GenScript

Thermo Fisher Scientific

Charles River Laboratories

Genewiz

Creative Biolabs

NovoPro Bioscience Inc.

ACGT, Inc.

Epoch Life Science

Eurofins Genomics

NZYtech

Synbio Technologies

Tsingke

GenCefe

Generay

Gene Site-Directed Mutagenesis Services Segment by Type

Synonymous Mutations

Missense Mutation

Nonsense Mutation

Gene Site-Directed Mutagenesis Services Segment by Application

Medical Industry

Biological Research

Others

Gene Site-Directed Mutagenesis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Site-Directed Mutagenesis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Site-Directed Mutagenesis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Site-Directed Mutagenesis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Site-Directed Mutagenesis Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Site-Directed Mutagenesis Services industry.

Chapter 3: Detailed analysis of Gene Site-Directed Mutagenesis Services companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Site-Directed Mutagenesis Servicesrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Synonymous Mutations Table 3. Key Players of Missense Mutation Table 4. Key Players of Nonsense Mutation Table 4. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Medical Industry Table 6. Key Players of Biological Research Table 7. Key Players of Others Table 8. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Gene Site-Directed Mutagenesis Services Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2021-2026) Table 11. Global Gene Site-Directed Mutagenesis Services Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Gene Site-Directed Mutagenesis Services Market Share by Region (2027-2032) Table 13. Gene Site-Directed Mutagenesis Services Industry Trends Table 14. Gene Site-Directed Mutagenesis Services Industry Drivers Table 15. Gene Site-Directed Mutagenesis Services Industry Opportunities and Challenges Table 16. Gene Site-Directed Mutagenesis Services Industry Restraints Table 17. Global Gene Site-Directed Mutagenesis Services Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Company (2021-2026) Table 19. Global Gene Site-Directed Mutagenesis Services Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gene Site-Directed Mutagenesis Services Key Company Head Office and Area Served Table 21. Global Gene Site-Directed Mutagenesis Services Company, Product Type & Application Table 22. Global Gene Site-Directed Mutagenesis Services Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Gene Site-Directed Mutagenesis Services by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Gene Site-Directed Mutagenesis Services Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2021-2026) Table 29. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2027-2032) Table 30. Global Gene Site-Directed Mutagenesis Services Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2021-2026) Table 34. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2027-2032) Table 35. Azenta Life Sciences Company Information Table 36. Azenta Life Sciences Business Overview Table 37. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product Portfolio Table 39. Azenta Life Sciences Recent Development Table 40. GenScript Company Information Table 41. GenScript Business Overview Table 42. GenScript Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. GenScript Gene Site-Directed Mutagenesis Services Product Portfolio Table 44. GenScript Recent Development Table 45. Thermo Fisher Scientific Company Information Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product Portfolio Table 49. Thermo Fisher Scientific Recent Development Table 50. Charles River Laboratories Company Information Table 51. Charles River Laboratories Business Overview Table 52. Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Charles River Laboratories Gene Site-Directed Mutagenesis Services Product Portfolio Table 54. Charles River Laboratories Recent Development Table 55. Genewiz Company Information Table 56. Genewiz Business Overview Table 57. Genewiz Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Genewiz Gene Site-Directed Mutagenesis Services Product Portfolio Table 59. Genewiz Recent Development Table 60. Creative Biolabs Company Information Table 61. Creative Biolabs Business Overview Table 62. Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Creative Biolabs Gene Site-Directed Mutagenesis Services Product Portfolio Table 64. Creative Biolabs Recent Development Table 65. NovoPro Bioscience Inc. Company Information Table 66. NovoPro Bioscience Inc. Business Overview Table 67. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product Portfolio Table 69. NovoPro Bioscience Inc. Recent Development Table 70. ACGT, Inc. Company Information Table 71. ACGT, Inc. Business Overview Table 72. ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. ACGT, Inc. Gene Site-Directed Mutagenesis Services Product Portfolio Table 74. ACGT, Inc. Recent Development Table 75. Epoch Life Science Company Information Table 76. Epoch Life Science Business Overview Table 77. Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Epoch Life Science Gene Site-Directed Mutagenesis Services Product Portfolio Table 79. Epoch Life Science Recent Development Table 80. Eurofins Genomics Company Information Table 81. Eurofins Genomics Business Overview Table 82. Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Eurofins Genomics Gene Site-Directed Mutagenesis Services Product Portfolio Table 84. Eurofins Genomics Recent Development Table 85. NZYtech Company Information Table 86. NZYtech Business Overview Table 87. NZYtech Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. NZYtech Gene Site-Directed Mutagenesis Services Product Portfolio Table 89. NZYtech Recent Development Table 90. Synbio Technologies Company Information Table 91. Synbio Technologies Business Overview Table 92. Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Synbio Technologies Gene Site-Directed Mutagenesis Services Product Portfolio Table 94. Synbio Technologies Recent Development Table 95. Tsingke Company Information Table 96. Tsingke Business Overview Table 97. Tsingke Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Tsingke Gene Site-Directed Mutagenesis Services Product Portfolio Table 99. Tsingke Recent Development Table 100. GenCefe Company Information Table 101. GenCefe Business Overview Table 102. GenCefe Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. GenCefe Gene Site-Directed Mutagenesis Services Product Portfolio Table 104. GenCefe Recent Development Table 105. Generay Company Information Table 106. Generay Business Overview Table 107. Generay Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 108. Generay Gene Site-Directed Mutagenesis Services Product Portfolio Table 109. Generay Recent Development Table 110. North America Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million) Table 111. North America Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (US$ Million) Table 112. North America Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million) Table 113. North America Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (US$ Million) Table 114. North America Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) Table 116. North America Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032) Table 117. Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million) Table 118. Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (US$ Million) Table 119. Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million) Table 120. Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (US$ Million) Table 121. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) Table 123. Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032) Table 124. China Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million) Table 125. China Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (US$ Million) Table 126. China Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million) Table 127. China Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (US$ Million) Table 128. Asia Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million) Table 129. Asia Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (US$ Million) Table 130. Asia Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million) Table 131. Asia Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (US$ Million) Table 132. Asia Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Asia Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) Table 134. Asia Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032) Table 135. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026) & (US$ Million) Table 136. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032) & (US$ Million) Table 137. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026) & (US$ Million) Table 138. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032) & (US$ Million) Table 139. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026) Table 141. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032) Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Gene Site-Directed Mutagenesis Services Product Image Figure 2. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gene Site-Directed Mutagenesis Services Market Share by Type: 2025 VS 2032 Figure 4. Synonymous Mutations Image Figure 5. Missense Mutation Image Figure 6. Nonsense Mutation Image Figure 7. Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Gene Site-Directed Mutagenesis Services Market Share by Application: 2025 VS 2032 Figure 9. Medical Industry Image Figure 10. Biological Research Image Figure 11. Others Image Figure 12. Global Gene Site-Directed Mutagenesis Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 14. Global Gene Site-Directed Mutagenesis Services Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Gene Site-Directed Mutagenesis Services Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Gene Site-Directed Mutagenesis Services Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gene Site-Directed Mutagenesis Services Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Type (2021-2032) Figure 21. Global Gene Site-Directed Mutagenesis Services Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Gene Site-Directed Mutagenesis Services Revenue Market Share by Application (2021-2032) Figure 23. North America Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 24. North America Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032) Figure 25. North America Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032) Figure 26. North America Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 27. United States Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 28. Canada Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 30. Europe Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032) Figure 32. Europe Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032) Figure 33. Europe Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 34. Germany Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 35. France Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 37. Italy Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 38. Russia Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 40. China Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 41. China Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032) Figure 42. China Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032) Figure 43. Asia Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 44. Asia Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032) Figure 45. Asia Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032) Figure 46. Asia Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 47. Japan Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 51. India Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 52. Australia Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032) Figure 57. Brazil Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 62. UAE Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 64. Chile Gene Site-Directed Mutagenesis Services Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Synonymous Mutations
  • Missense Mutation
  • Nonsense Mutation
Applications
  • Medical Industry
  • Biological Research
  • Others
Companies covered
  • Azenta Life Sciences
  • GenScript
  • Thermo Fisher Scientific
  • Charles River Laboratories
  • Genewiz
  • Creative Biolabs
  • NovoPro Bioscience Inc.
  • ACGT, Inc.
  • Epoch Life Science
  • Eurofins Genomics
  • NZYtech
  • Synbio Technologies
  • Tsingke
  • GenCefe
  • Generay

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Synonymous Mutations
  5. 1.2.3 Missense Mutation
  6. 1.2.4 Nonsense Mutation
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Gene Site-Directed Mutagenesis Services Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Medical Industry
  10. 1.3.3 Biological Research
  11. 1.3.4 Others
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Gene Site-Directed Mutagenesis Services Growth Trends by Region
  14. 1.5.1 Global Gene Site-Directed Mutagenesis Services Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Gene Site-Directed Mutagenesis Services Market Size by Region (2021-2026)
  16. 1.5.3 Gene Site-Directed Mutagenesis Services Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Gene Site-Directed Mutagenesis Services Market Dynamics
  1. 2.1 Gene Site-Directed Mutagenesis Services Industry Trends
  2. 2.2 Gene Site-Directed Mutagenesis Services Industry Drivers
  3. 2.3 Gene Site-Directed Mutagenesis Services Industry Opportunities and Challenges
  4. 2.4 Gene Site-Directed Mutagenesis Services Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gene Site-Directed Mutagenesis Services Revenue by Company (2021-2026)
  2. 3.2 Global Gene Site-Directed Mutagenesis Services Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gene Site-Directed Mutagenesis Services Key Company Head office and Area Served
  4. 3.4 Global Gene Site-Directed Mutagenesis Services Company, Product Type & Application
  5. 3.5 Global Gene Site-Directed Mutagenesis Services Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gene Site-Directed Mutagenesis Services Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gene Site-Directed Mutagenesis Services Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gene Site-Directed Mutagenesis Services Tier 1, Tier 2, and Tier 3
4 Gene Site-Directed Mutagenesis Services Market by Type
  1. 4.1 Global Gene Site-Directed Mutagenesis Services Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2032)
  3. 4.3 Global Gene Site-Directed Mutagenesis Services Market Size Share by Type (2021-2032)
5 Gene Site-Directed Mutagenesis Services Market by Application
  1. 5.1 Global Gene Site-Directed Mutagenesis Services Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2032)
  3. 5.3 Global Gene Site-Directed Mutagenesis Services Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Azenta Life Sciences
  2. 6.1.1 Azenta Life Sciences Company Information
  3. 6.1.2 Azenta Life Sciences Business Overview
  4. 6.1.3 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Azenta Life Sciences Gene Site-Directed Mutagenesis Services Product Portfolio
  6. 6.1.5 Azenta Life Sciences Recent Developments
  7. 6.2 GenScript
  8. 6.2.1 GenScript Company Information
  9. 6.2.2 GenScript Business Overview
  10. 6.2.3 GenScript Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 GenScript Gene Site-Directed Mutagenesis Services Product Portfolio
  12. 6.2.5 GenScript Recent Developments
  13. 6.3 Thermo Fisher Scientific
  14. 6.3.1 Thermo Fisher Scientific Company Information
  15. 6.3.2 Thermo Fisher Scientific Business Overview
  16. 6.3.3 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Thermo Fisher Scientific Gene Site-Directed Mutagenesis Services Product Portfolio
  18. 6.3.5 Thermo Fisher Scientific Recent Developments
  19. 6.4 Charles River Laboratories
  20. 6.4.1 Charles River Laboratories Company Information
  21. 6.4.2 Charles River Laboratories Business Overview
  22. 6.4.3 Charles River Laboratories Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Charles River Laboratories Gene Site-Directed Mutagenesis Services Product Portfolio
  24. 6.4.5 Charles River Laboratories Recent Developments
  25. 6.5 Genewiz
  26. 6.5.1 Genewiz Company Information
  27. 6.5.2 Genewiz Business Overview
  28. 6.5.3 Genewiz Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Genewiz Gene Site-Directed Mutagenesis Services Product Portfolio
  30. 6.5.5 Genewiz Recent Developments
  31. 6.6 Creative Biolabs
  32. 6.6.1 Creative Biolabs Company Information
  33. 6.6.2 Creative Biolabs Business Overview
  34. 6.6.3 Creative Biolabs Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Creative Biolabs Gene Site-Directed Mutagenesis Services Product Portfolio
  36. 6.6.5 Creative Biolabs Recent Developments
  37. 6.7 NovoPro Bioscience Inc.
  38. 6.7.1 NovoPro Bioscience Inc. Company Information
  39. 6.7.2 NovoPro Bioscience Inc. Business Overview
  40. 6.7.3 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 NovoPro Bioscience Inc. Gene Site-Directed Mutagenesis Services Product Portfolio
  42. 6.7.5 NovoPro Bioscience Inc. Recent Developments
  43. 6.8 ACGT, Inc.
  44. 6.8.1 ACGT, Inc. Company Information
  45. 6.8.2 ACGT, Inc. Business Overview
  46. 6.8.3 ACGT, Inc. Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 ACGT, Inc. Gene Site-Directed Mutagenesis Services Product Portfolio
  48. 6.8.5 ACGT, Inc. Recent Developments
  49. 6.9 Epoch Life Science
  50. 6.9.1 Epoch Life Science Company Information
  51. 6.9.2 Epoch Life Science Business Overview
  52. 6.9.3 Epoch Life Science Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Epoch Life Science Gene Site-Directed Mutagenesis Services Product Portfolio
  54. 6.9.5 Epoch Life Science Recent Developments
  55. 6.10 Eurofins Genomics
  56. 6.10.1 Eurofins Genomics Company Information
  57. 6.10.2 Eurofins Genomics Business Overview
  58. 6.10.3 Eurofins Genomics Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Eurofins Genomics Gene Site-Directed Mutagenesis Services Product Portfolio
  60. 6.10.5 Eurofins Genomics Recent Developments
  61. 6.11 NZYtech
  62. 6.11.1 NZYtech Company Information
  63. 6.11.2 NZYtech Business Overview
  64. 6.11.3 NZYtech Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 NZYtech Gene Site-Directed Mutagenesis Services Product Portfolio
  66. 6.11.5 NZYtech Recent Developments
  67. 6.12 Synbio Technologies
  68. 6.12.1 Synbio Technologies Company Information
  69. 6.12.2 Synbio Technologies Business Overview
  70. 6.12.3 Synbio Technologies Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Synbio Technologies Gene Site-Directed Mutagenesis Services Product Portfolio
  72. 6.12.5 Synbio Technologies Recent Developments
  73. 6.13 Tsingke
  74. 6.13.1 Tsingke Company Information
  75. 6.13.2 Tsingke Business Overview
  76. 6.13.3 Tsingke Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Tsingke Gene Site-Directed Mutagenesis Services Product Portfolio
  78. 6.13.5 Tsingke Recent Developments
  79. 6.14 GenCefe
  80. 6.14.1 GenCefe Company Information
  81. 6.14.2 GenCefe Business Overview
  82. 6.14.3 GenCefe Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 GenCefe Gene Site-Directed Mutagenesis Services Product Portfolio
  84. 6.14.5 GenCefe Recent Developments
  85. 6.15 Generay
  86. 6.15.1 Generay Company Information
  87. 6.15.2 Generay Business Overview
  88. 6.15.3 Generay Gene Site-Directed Mutagenesis Services Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Generay Gene Site-Directed Mutagenesis Services Product Portfolio
  90. 6.15.5 Generay Recent Developments
7 North America
  1. 7.1 North America Gene Site-Directed Mutagenesis Services Market Size (2021-2032)
  2. 7.2 North America Gene Site-Directed Mutagenesis Services Market Size by Type
  3. 7.2.1 North America Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)
  4. 7.2.2 North America Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032)
  5. 7.2.3 North America Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032)
  6. 7.3 North America Gene Site-Directed Mutagenesis Services Market Size by Application
  7. 7.3.1 North America Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)
  8. 7.3.2 North America Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032)
  9. 7.3.3 North America Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032)
  10. 7.4 North America Gene Site-Directed Mutagenesis Services Market Size by Country
  11. 7.4.1 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  13. 7.4.3 North America Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032)
  14. 7.4.4 North America Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gene Site-Directed Mutagenesis Services Market Size (2021-2032)
  2. 8.2 Europe Gene Site-Directed Mutagenesis Services Market Size by Type
  3. 8.2.1 Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032)
  6. 8.3 Europe Gene Site-Directed Mutagenesis Services Market Size by Application
  7. 8.3.1 Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032)
  10. 8.4 Europe Gene Site-Directed Mutagenesis Services Market Size by Country
  11. 8.4.1 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gene Site-Directed Mutagenesis Services Market Size (2021-2032)
  2. 9.2 China Gene Site-Directed Mutagenesis Services Market Size by Type
  3. 9.2.1 China Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)
  4. 9.2.2 China Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032)
  5. 9.2.3 China Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032)
  6. 9.3 China Gene Site-Directed Mutagenesis Services Market Size by Application
  7. 9.3.1 China Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)
  8. 9.3.2 China Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032)
  9. 9.3.3 China Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gene Site-Directed Mutagenesis Services Market Size (2021-2032)
  2. 10.2 Asia Gene Site-Directed Mutagenesis Services Market Size by Type
  3. 10.2.1 Asia Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032)
  6. 10.3 Asia Gene Site-Directed Mutagenesis Services Market Size by Application
  7. 10.3.1 Asia Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032)
  10. 10.4 Asia Gene Site-Directed Mutagenesis Services Market Size by Country
  11. 10.4.1 Asia Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gene Site-Directed Mutagenesis Services Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst